Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines-Reference-Cited by-同舟云学术

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines

Published:2022-04-12 Issue:6 Volume:21 Page:2407-2416
ISSN:1473-2130
Container-title:Journal of Cosmetic Dermatology
language:en
Short-container-title:J of Cosmetic Dermatology

Author:

Dayan Steven¹,Joseph John²,Moradi Amir³,Lorenc Z. Paul⁴,Coleman Kyle⁵,Ablon Glynis⁶,Kaufman‐Janette Joely⁷^ORCID,Cox Sue Ellen⁸,Campbell Andrew⁹,Munavalli Girish¹⁰,Prygova Inna¹¹

Affiliation:

1. DeNova Research Chicago Illinois USA

2. Clinical Testing of Beverly Hills Encino California USA

3. Moradi M.D. Vista California USA

4. Lorenc Aesthetic Plastic Surgery Center New York USA

5. Etre Cosmetic Dermatology and Laser Center New Orleans Louisina USA

6. Ablon Skin Institute and Research Center Manhattan Beach California USA

7. Skin Research Institute, LLC, Coral Gables Florida USA

8. Aesthetic Solutions, PA Chapel Hill North Carolina USA

9. Quintessa Aesthetic Center – EthiQ2 Research, LLC Mequon Wisconsin USA

10. Dermatology, Laser & Vein Specialists of the Carolinas PLLC Charlotte North Carolina USA

11. Galderma Uppsala Sweden

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.14906

Reference25 articles.

1. The Aesthetic Society when citing statistical data. Aesthetic plastic surgery national databank statistics 2020. Available at:https://cdn.surgery.org/media/statistics/aestheticplasticsurgerynationaldatabank‐2020stats.pdf[accessed January 2022]

2. Treating glabellar lines with botulinum toxin type A‐hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction;Boulle K;Clin Interv Aging,2010

3. Ipsen Biopharmaceuticals Inc.Dysport®(abobotulinumtoxinA) for injection for intramuscular use. Prescribing information. Available at:https://www.ipsen.com/websites/Ipsen_Online/wp‐content/uploads/sites/9/2019/01/21084019/Dysport_Full_Prescribing_Information.pdf[accessed January 2022]

4. Galderma UK.Azzalure 125 Speywood units powder for solution for injection. Summary of product characteristics. September 2021. Available at:https://www.medicines.org.uk/emc/product/6584[accessed January 2022].

5. Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of Current Data on Duration of Effect in Glabellar Lines After Treatment With AbobotulinumtoxinA 50 U;Dermatologic Surgery;2024-07-24

2. LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials;Dermatologic Surgery;2024-03-12

3. Tailored Indications for Different Neurotoxins;Plastic and Reconstructive Surgery - Global Open;2023-11

4. Consensus Statement on the Use of Botulinum Neurotoxin in the Middle East;Clinical, Cosmetic and Investigational Dermatology;2023-10

5. Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy;Dermatology and Therapy;2023-06-14